Abstract:Species of Ganoderma, commonly called reishi (in Japan) or lingzhi (in China), have been used in traditional medicine for thousands of years, and their use has gained interest from pharmaceutical industries in recent years. Globally, the taxonomy of Ganoderma species is chaotic, and the taxon name Ganoderma lucidum has been used for most laccate (shiny) Ganoderma species. However, it is now known that G. lucidum sensu stricto has a limited native distribution in Europe and some parts of China. It is likely that differences in the quality and quantity of medicinally relevant chemicals occur among Ganoderma species. To determine what species are being sold in commercially available products, twenty manufactured products (e.g., pills, tablets, teas, etc.) and seventeen grow your own (GYO) kits labeled as containing G. lucidum were analyzed. DNA was extracted, and the internal transcribed spacer (ITS) region and translation elongation factor 1-alpha (tef1α) were sequenced with specific fungal primers. The majority (93%) of the manufactured reishi products and almost half of the GYO kits were identified as Ganoderma lingzhi. G. lingzhi is native to Asia and is the most widely cultivated and studied taxon for medicinal use. Illumina MiSeq sequencing of the ITS1 region was performed to determine if multiple Ganoderma species were present. None of the manufactured products tested contained G. lucidum sensu stricto, and it was detected in only one GYO kit. G. lingzhi was detected in most products, but other Ganoderma species were also present, including G. applanatum, G. australe, G. gibbosum, G. sessile, and G. sinense. Our results indicate that the content of these products vary and that better labeling is needed to inform consumers before these products are ingested or marketed as medicine. Of the 17 GYO kits tested, 11 kits contained Ganoderma taxa that are not native to the United States. If fruiting bodies of exotic Ganoderma taxa are cultivated, these GYO kits will likely end up in the environment. The effects of these exotic species to natural ecosystems needs investigation.

Germplasm resources and secondary metabolism regulation in Reishi mushroom (Ganoderma lucidum)

Germplasm resources and secondary metabolism regulation in Reishi mushroom <i>(Ganoderma lucidum)</i>

Identification of a Novel Metabolic Target for Bioactive Triterpenoids Biosynthesis in <i>Ganoderma</i> lucidum

Shedding Light on the Mechanisms Underlying the Environmental Regulation of Secondary Metabolite Ganoderic Acid in Ganoderma Lucidum Using Physiological and Genetic Methods.

From Taxonomy and Industry to Genetics: Fungal Biology in China.

Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum

Ganoderma lucidum: Insight into antimicrobial and antioxidant properties with development of secondary metabolites

Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties

Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction.

Ganoderma Lucidum: an Emerging Medicinal Model Fungus for Study of the Biosynthesis of Natural Medicines

The Genome Of Ganderma Lucidum Provide Insights Into Triterpense Biosynthesis And Wood Degradation

Ganoderma lucidum triterpenoids investigating their role in medicinal applications and genomic protection

Evaluation of Some Active Nutrients, Biological Compounds and Health Benefits of Reishi Mushroom (ganoderma Lucidum)

Transcriptome and metabolome analyses reveal transcription factors regulating ganoderic acid biosynthesis in Ganoderma lucidum development

Ganoderma lucidum and its pharmaceutically active compounds

Antitumour, Antimicrobial, Antioxidant and Antiacetylcholinesterase Effect of Ganoderma Lucidum Terpenoids and Polysaccharides: A Review

Research Progress on the Biological Activity of Ganoderic Acids in Ganoderma lucidum over the Last Five Years

Ganodermataceae: Natural Products and Their Related Pharmacological Functions.

Ganoderma lucidum: A Potent Pharmacological Macrofungus

Identifying the “Mushroom of Immortality”: Assessing the Ganoderma Species Composition in Commercial Reishi Products

Changes of Active Substances in Ganoderma lucidum during Different Growth Periods and Analysis of Their Molecular Mechanism